ulcerative-colitis

Documents about ulcerative-colitis

• Remote Ischemic Conditioning in Patients With Ulcerative Colitis#884901ClinicalTrials.gov
• A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis#807695ClinicalTrials.gov
• Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis#855002ClinicalTrials.gov
• A Study of Cizutamig for Patients With Ulcerative Colitis#865425ClinicalTrials.gov
• A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis#868990ClinicalTrials.gov
• Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients#979174ClinicalTrials.gov
• An unusual case of intestinal obstruction in ulcerative colitis#291434Gestión del Repositorio Documental de la Universidad de Salamanca
• Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis#835223ClinicalTrials.gov
• Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC Study#836509ClinicalTrials.gov
• LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)#837110ClinicalTrials.gov
• An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis#849808ClinicalTrials.gov
• Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares#878289ClinicalTrials.gov
• The Use of Butyrate Therapy in Pediatric Ulcerative Colitis#1008261ClinicalTrials.gov
• An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice#967503ClinicalTrials.gov
• Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)#886532ClinicalTrials.gov
• VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis#908571ClinicalTrials.gov
• Food Limitations In Crohn's Disease and Ulcerative coliTis#911990ClinicalTrials.gov
• Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures#152457ClinicalTrials.gov
• Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative Colitis#852590ClinicalTrials.gov
• An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis#860274ClinicalTrials.gov
• Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy#885332ClinicalTrials.gov
• A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease#887992ClinicalTrials.gov
• Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis#896482ClinicalTrials.gov
• Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis#901857ClinicalTrials.gov
• Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis#903065ClinicalTrials.gov
• Efficacy and Safety of BBT-401-1S in Ulcerative Colitis#904435ClinicalTrials.gov
• ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis#979192ClinicalTrials.gov
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis#874350ClinicalTrials.gov
• AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis#829028ClinicalTrials.gov
• Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients#873339ClinicalTrials.gov
• Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis#800535ClinicalTrials.gov
• Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis#802591ClinicalTrials.gov
• CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study#802694ClinicalTrials.gov
• The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis#836088ClinicalTrials.gov
• The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis#854037ClinicalTrials.gov
• Efficacy of Cyclosporine Rescue Therapy in Acute Ulcerative Colitis.#895843ClinicalTrials.gov
• COlonic Salvage by Therapeutic Appendectomy.#993245ClinicalTrials.gov
• Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis#849789ClinicalTrials.gov
• A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis#311143ClinicalTrials.gov
• Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis#356616ClinicalTrials.gov
• A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis#810533ClinicalTrials.gov
• Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis#839997ClinicalTrials.gov
• Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis#857540ClinicalTrials.gov
• Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis#876702ClinicalTrials.gov
• An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)#881843ClinicalTrials.gov
• Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)#900637ClinicalTrials.gov
• Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476#904183ClinicalTrials.gov
• Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery#905236ClinicalTrials.gov
• TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS#906507ClinicalTrials.gov
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.#907440ClinicalTrials.gov